Pharmaceutical manufacturers of Procaine

Biesterfeld Spezialchemie stands as a prominent global distributor of specialty chemical products, pharmaceuticals, and food ingredients. The organization provides comprehensive industry expertise and custom, application-oriented technical guidance across a varied product range focusing on the needs of specific sectors, such as composites and tooling, personal care and hygiene, healthcare, paints and coatings, adhesives, polyurethane, construction, nutrition, nutraceuticals, and electrical, electronic, and energy.

Leading Italian expert in personalized development and contract manufacturing of Active Pharmaceutical Ingredients, ICROM is the exclusive firm for APIs. Utilizing advanced expertise, ICROM constructs high-tech solutions for synthesizing intricate molecules and creating adaptable, expandable, and economical processes tailored to clients’ requirements. With varying production capacities in 4 cutting-edge manufacturing facilities sanctioned by AIFA, USFDA, PMDA, KFDA, ICROM is the preferred partner for CDMO of NCEs, advanced generics, and your drive for innovation.

Our company is a manufacturer of APIs, with a history of nearly 70 years supplying pharmaceutical substances in Japan and worldwide. We produce a broad range of APIs under a robust control system that adheres to international GMP regulations, including ICH guidelines. Our production facilities, with FDA approval, operate daily with a focus on quality, productivity, costs, safety, and environmental impact.

Zhejiang Bamboo Pharmaceuticals emerged in 2020 as a pioneering and eco-friendly producer of top-notch pharmaceutical API. Its expansive facility spans approximately 66,000m2, with a dedicated plant area covering 50,000 m2. The company specializes in gabapentin, benzocaine, pregabalin, tranexamic acid, levocarnitine, as well as a food additive: dimethyl dicarbonate. Moreover, each API is accompanied by US DMF, CEP certificate, and written confirmation, solidifying its commitment to quality and compliance. Zhejiang Bamboo Pharmaceuticals sets itself apart as a contemporary and regulatory organization, focusing on both API and formulation drug manufacturing. While the formulation drugs primarily target the domestic market, the company aspires to secure a prominent position as a major supplier for the Chinese '4 + 7' volume procurement program.

FLARER is a company specializing in the supply of pharmaceutical, beauty, and nutritional raw materials. With its exclusive agents and a vast network of connections with suppliers globally, Flarer is the perfect ally for sourcing high-quality raw materials from accredited suppliers. Additionally, Flarer can assist its clients throughout the regulatory procedures.